$PTLA Folks need to remember to always be aware of the limits of the downside also. How low can this go based on being such a successful launch??? You already generated 36M in Q3 of full marketing launch EU that company said is going to respond quite well, reimbursement is spectacular, almost all physicians guides now recommend A2 AND YOU GUYS FREAK ABOUT A STUPID BEAR RAID???? WE HAVE 24% SI BUILD ON EXPECTATIONS OF AN ANDEXXA FIASCO!!!!!!! The SHort interest holders know their seats are slowly warming up and will be unbearable come Q4 2018 and going into Q1 2020. He future is written all over this launch and it is one of the TOP FIVE LAUNCHES OF HOSPITAL DRUGS IN THE LAST 30 YEARS!!!!